BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li N, Zhang C, Meng Z, Xu K, He X, Yu Y, Jia Q, Li X, Liu X, Wang X. Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer. Medicine (Baltimore) 2018;97:e12242. [PMID: 30200153 DOI: 10.1097/MD.0000000000012242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Huang Z, He X, Zheng X, Jia Q, Tan J, Fan Y, Lou C, Meng Z. Blood prognostic predictors of treatment response for patients with papillary thyroid cancer. Biosci Rep 2020;40:BSR20202544. [PMID: 33015713 DOI: 10.1042/BSR20202544] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhou L, Jiang J, Fu Y, Zhang D, Li T, Fu Q, Yan C, Zhong Y, Dionigi G, Liang N, Sun H. Diagnostic performance of Midkine ratios in fine-needle aspirates for evaluation of Cytologically indeterminate thyroid nodules. Diagn Pathol 2021;16:92. [PMID: 34689799 DOI: 10.1186/s13000-021-01150-y] [Reference Citation Analysis]
3 Wang W, Chang J, Jia B, Liu J. The Blood Biomarkers of Thyroid Cancer. Cancer Manag Res 2020;12:5431-8. [PMID: 32753960 DOI: 10.2147/CMAR.S261170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]